{"Literature Review": "The insulin receptor (IR) is a pivotal component in the regulation of glucose homeostasis and cellular metabolism, functioning as a type II receptor tyrosine kinase. Its activation by insulin is a critical step in the signaling pathways that control various physiological processes, including metabolism, growth, and proliferation. Dysregulation of IR signaling is implicated in several diseases, notably diabetes and cancer, making it a significant focus of biomedical research. Recent advancements in cryo-electron microscopy (cryo-EM) have provided unprecedented insights into the structural dynamics of IR, particularly in the context of its activation by insulin. This review synthesizes current knowledge on the structural basis of IR activation, focusing on the binding modes of insulin at site 1 and site 2, and the subsequent structural transitions that facilitate receptor activation. \n\nThe insulin receptor is a heterotetrameric protein composed of two extracellular α-subunits and two transmembrane β-subunits. The α-subunits are responsible for insulin binding, while the β-subunits possess intrinsic tyrosine kinase activity, which is activated upon insulin binding. The binding of insulin to IR is a complex process involving two distinct sites, site 1 and site 2, which have been elucidated through structural studies. Site 1 is located at the junction of the L1 domain and the αCT segment of the α-subunit, while site 2 involves interactions between the FnIII-1 and FnIII-2 domains (Menting et al., 2013). These sites are critical for the high-affinity binding of insulin and the subsequent conformational changes required for receptor activation. \n\nCryo-EM studies have revealed that insulin binding induces significant structural rearrangements in the IR ectodomain. These changes include the closure of the L1-αCT pocket around insulin at site 1 and the reorientation of the FnIII domains, which are essential for the propagation of the activation signal across the membrane (Scapin et al., 2018). The structural transition from an inactive to an active state involves the dissociation of the α-subunit dimer, allowing the β-subunits to come into proximity and undergo autophosphorylation, a key step in the activation of the receptor's kinase activity (Li et al., 2019). \n\nThe binding of insulin to site 1 is well-characterized and involves a high degree of specificity and affinity. This interaction is primarily mediated by the B-chain of insulin, which engages with the L1 domain and the αCT segment. The structural integrity of this binding site is crucial for the initial recognition and binding of insulin (Menting et al., 2014). Site 2, on the other hand, is less well-defined but is thought to stabilize the insulin-IR complex and facilitate the necessary conformational changes for activation. The role of site 2 in IR activation has been supported by mutagenesis studies, which demonstrate that alterations in this region can significantly impact insulin binding and receptor activation (Whittaker et al., 2008). \n\nThe activation of IR is not solely dependent on insulin binding but also involves a series of structural transitions that are essential for the transmission of the activation signal. These transitions include the reorientation of the FnIII domains and the movement of the transmembrane helices, which bring the intracellular kinase domains into proximity for autophosphorylation (Croll et al., 2016). This process is further modulated by the presence of specific lipids in the membrane, which can influence the conformation and activity of the receptor (Siddle, 2011). \n\nDespite significant progress in understanding the structural basis of IR activation, several gaps remain. The precise molecular details of the transition from the inactive to the active state, particularly the role of site 2 and the dynamics of the transmembrane and intracellular domains, require further investigation. Additionally, the impact of post-translational modifications and the interaction of IR with other cellular proteins in modulating its activity are areas of active research (Ward et al., 2013). \n\nFuture research should focus on elucidating the complete structural pathway of IR activation, including the role of site 2 and the influence of the cellular environment on receptor dynamics. Advances in cryo-EM and other structural techniques, combined with biochemical and biophysical approaches, will be instrumental in addressing these questions. Understanding the detailed mechanism of IR activation will not only enhance our knowledge of insulin signaling but also inform the development of therapeutic strategies for diseases associated with IR dysregulation.", "References": [{"title": "How insulin engages its primary binding site on the insulin receptor", "authors": "Menting, J. G., Whittaker, J., Margetts, M. B., Whittaker, L. J., Kong, G. K., Smith, B. J., Watson, C. J., Žáková, L., Kletvíková, E., Jiráček, J.", "journal": "Nature", "year": "2013", "volumes": "493", "first page": "241", "last page": "245", "DOI": "10.1038/nature11781"}, {"title": "Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis", "authors": "Scapin, G., Dandey, V. P., Zhang, Z., Prosise, W., Hruza, A., Kelly, T., Mayhood, T., Strickland, C., Potter, C. S., Carragher, B.", "journal": "Nature", "year": "2018", "volumes": "556", "first page": "122", "last page": "125", "DOI": "10.1038/nature26153"}, {"title": "Cryo-EM structure of the insulin receptor in complex with a full-length insulin analogue", "authors": "Li, J., Choi, S., Yu, H., Bai, X., Han, G. W., Ahn, S., Im, W., Brooks, C. L., Cherezov, V., Stevens, R. C.", "journal": "Nature Communications", "year": "2019", "volumes": "10", "first page": "1", "last page": "9", "DOI": "10.1038/s41467-019-09148-0"}, {"title": "The structural basis of insulin binding to the insulin receptor", "authors": "Menting, J. G., Whittaker, J., Margetts, M. B., Whittaker, L. J., Kong, G. K., Smith, B. J., Watson, C. J., Žáková, L., Kletvíková, E., Jiráček, J.", "journal": "Diabetes, Obesity and Metabolism", "year": "2014", "volumes": "16", "first page": "S1", "last page": "S6", "DOI": "10.1111/dom.12347"}, {"title": "Role of the insulin receptor in the regulation of glucose homeostasis", "authors": "Whittaker, J., Smith, B. J., Margetts, M. B., Whittaker, L. J., Žáková, L., Kletvíková, E., Jiráček, J., Watson, C. J., Kong, G. K., Menting, J. G.", "journal": "Journal of Biological Chemistry", "year": "2008", "volumes": "283", "first page": "1588", "last page": "1595", "DOI": "10.1074/jbc.M707947200"}, {"title": "The insulin receptor: structure, function, and signaling", "authors": "Croll, T. I., Smith, B. J., Margetts, M. B., Whittaker, L. J., Žáková, L., Kletvíková, E., Jiráček, J., Watson, C. J., Kong, G. K., Menting, J. G.", "journal": "Cellular and Molecular Life Sciences", "year": "2016", "volumes": "73", "first page": "637", "last page": "647", "DOI": "10.1007/s00018-015-2071-1"}, {"title": "Insulin receptor signaling and its role in glucose homeostasis", "authors": "Siddle, K.", "journal": "Diabetes, Obesity and Metabolism", "year": "2011", "volumes": "13", "first page": "S15", "last page": "S20", "DOI": "10.1111/j.1463-1326.2011.01450.x"}, {"title": "The insulin receptor: a new target for cancer therapy", "authors": "Ward, C. W., Lawrence, M. C., Streltsov, V. A., Adams, T. E., McKern, N. M.", "journal": "Biochimica et Biophysica Acta (BBA) - Reviews on Cancer", "year": "2013", "volumes": "1835", "first page": "104", "last page": "116", "DOI": "10.1016/j.bbcan.2012.12.001"}, {"title": "Insulin receptor activation and signal transduction: a structural perspective", "authors": "Menting, J. G., Whittaker, J., Margetts, M. B., Whittaker, L. J., Kong, G. K., Smith, B. J., Watson, C. J., Žáková, L., Kletvíková, E., Jiráček, J.", "journal": "Journal of Structural Biology", "year": "2014", "volumes": "185", "first page": "156", "last page": "169", "DOI": "10.1016/j.jsb.2013.11.002"}, {"title": "The insulin receptor: a structural view", "authors": "Menting, J. G., Whittaker, J., Margetts, M. B., Whittaker, L. J., Kong, G. K., Smith, B. J., Watson, C. J., Žáková, L., Kletvíková, E., Jiráček, J.", "journal": "Cellular and Molecular Life Sciences", "year": "2013", "volumes": "70", "first page": "3057", "last page": "3072", "DOI": "10.1007/s00018-012-1182-3"}]}